Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic

E Aso, I Ferrer - Frontiers in pharmacology, 2014 - frontiersin.org
The limited effectiveness of current therapies against Alzheimer's disease (AD) highlights
the need for intensifying research efforts devoted to developing new agents for preventing or …

Impact of cannabis use on the development of psychotic disorders

ST Wilkinson, R Radhakrishnan, DC D'Souza - Current addiction reports, 2014 - Springer
The link between cannabis use and psychosis comprises three distinct relationships: acute
psychosis associated with cannabis intoxication; acute psychosis that lasts beyond the …

Presynaptic long-term depression mediated by Gi/o-coupled receptors

BK Atwood, DM Lovinger, BN Mathur - Trends in neurosciences, 2014 - cell.com
Long-term depression (LTD) of the efficacy of synaptic transmission is now recognized as an
important mechanism for the regulation of information storage and the control of actions, as …

Therapeutic potential of cannabinoids in neurodegenerative disorders: a selective review

L Velayudhan, E Van Diepen… - Current …, 2014 - ingentaconnect.com
The endocannabinoid system (ECS) is now recognised as an important modulator of various
central nervous system processes. More recently, an increasing body of evidence has …

Interplay between synaptic endocannabinoid signaling and metaplasticity in neuronal circuit function and dysfunction

M Melis, B Greco, R Tonini - European Journal of Neuroscience, 2014 - Wiley Online Library
Synaptic neuromodulation acts across different functional domains to regulate cognitive
processing and behavior. Recent challenges are related to elucidating the molecular and …

A systems pharmacology perspective on the clinical development of fatty acid amide hydrolase inhibitors for pain

N Benson, E Metelkin, O Demin, GL Li… - CPT …, 2014 - Wiley Online Library
The level of the endocannabinoid anandamide is controlled by fatty acid amide hydrolase
(FAAH). In 2011, PF‐04457845, an irreversible inhibitor of FAAH, was progressed to phase …

Cannabinoid receptor type 1 activation by arachidonylcyclopropylamide in rat aortic rings causes vasorelaxation involving calcium-activated potassium channel …

E Sánchez-Pastor, F Andrade… - European journal of …, 2014 - Elsevier
Cannabinoids are key regulators of vascular tone, some of the mechanisms involved include
the activation of cannabinoid receptor types 1 and 2 (CB); the transient receptor potential …

Anandamide in primary sensory neurons: too much of a good thing?

J Sousa‐Valente, A Varga, K Ananthan… - European Journal of …, 2014 - Wiley Online Library
The quest for possible targets for the development of novel analgesics has identified the
activation of the cannabinoid type 1 (CB 1) receptor outside the CNS as a potential means of …

Neuromodulators, stress and plasticity: a role for endocannabinoid signalling

L Senst, J Bains - Journal of Experimental biology, 2014 - journals.biologists.com
Any unanticipated threat to survival triggers an immediate sequence of events in the brain
that culminate in a coordinated neural, endocrine and behavioural response. There is …

Regulatory effects of anandamide on intracellular Ca2+ concentration increase in trigeminal ganglion neurons

Y Zhang, H Xie, G Lei, F Li, J Pan, C Liu… - Neural Regeneration …, 2014 - journals.lww.com
Activation of cannabinoid receptor type 1 on presynaptic neurons is postulated to suppress
neurotransmission by decreasing Ca 2+ influx through high voltage-gated Ca 2+ channels …